Brands: Abilify · Aripiprazole
Average across 172 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 65 | SUPPLYING |
| Alembic Pharmaceuticals Limited | generic | 64 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 42 | SUPPLYING |
| Solco Healthcare US, LLC | unknown | 36 | SUPPLYING |
| Torrent Pharmaceuticals Limited | unknown | 30 | SUPPLYING |
| Ascend Laboratories, LLC | generic | 28 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 25 | SUPPLYING |
| ScieGen Pharmaceuticals Inc | unknown | 24 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 24 | SUPPLYING |
| XLCare Pharmaceuticals Inc. | unknown | 24 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 24 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 18 | SUPPLYING |
| Unichem Pharmaceuticals (USA), Inc. | unknown | 18 | SUPPLYING |
| Macleods Pharmaceuticals Limited | generic | 18 | SUPPLYING |
| Otsuka America Pharmaceutical, Inc. | unknown | 15 | SUPPLYING |
+ 19 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg. — Recalling firm: Ajanta Pharma USA Inc — U.S. Nationwide
Superpotent drug — Recalling firm: Ascend Laboratories, LLC — Nationwide in the USA.
Cross Contamination with Other Products — Recalling firm: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — USA nationwide.
Cross Contamination with Other Products — Recalling firm: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — USA nationwide.
Cross Contamination with Other Products — Recalling firm: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — USA nationwide.
Cross Contamination with Other Products — Recalling firm: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — USA nationwide.
Out of specification (OOS) for Spectroscopic Identification test by IR. — Recalling firm: Ascend Laboratories, LLC — Nationwide in the USA
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — Recalling firm: CARDINAL HEALTHCARE — Nationwide USA
Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count. — Recalling firm: Alembic Pharmaceuticals Limited — Nationwide in the U.S.
CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications. — Recalling firm: AMERICAN HEALTH PACKAGING — Nationwide in the USA
CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications. — Recalling firm: Hetero Labs, Ltd. - Unit III — NJ Only
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed. — Recalling firm: Bristol Myers Squibb Manufacturing Company — LA, TN, CA
